Extending gains for the second straight session, the BSE Sensex gained as much as 916 points, or 1.15%, to 80,393 during the session so far. In a similar trend, the NSE Nifty surged 274 points, or ...

Swiggy aims to raise a total of ₹11,327.43 crore from this IPO, marking it as the second-largest IPO in India this year after ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

The current strategy focuses on aggressive debt reduction, but this alone won't drive significant stock price improvement.

India's Mankind Pharma reported a better-than-expected second-quarter profit on Tuesday, driven by strong demand for its drugs to treat long-term illnesses, such as diabetes and cardiovascular ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved to be ...

On Cenexi, co-reiterated Its Aim To Break-Even At eu200 m p.a. Run-rate Incremental Growth For Co's Base Biz In US Is Likely To Come At Cost Of Margin Disclaimer: The views and investment tips ...

As the star cricketer brings in his birthday today, we look at his stellar performances both on and off the field ...

In the worst-case scenario, an unfavourable judgment would prevent Sun Pharma from launching Leqselvi until the patent expires, delaying its market entry.

In the corresponding quarter of the previous fiscal, Sun Pharma Advanced Research Company posted a net loss of ₹86.4 crore, ...

According to Citi, the delay in the launch of Sun Pharma's alopecia areata drug, Leqselvi, could impact its near-term ...

The NSE Nifty tanked 229.4 points to 24,074.95. From the 30-share Sensex pack, Sun Pharma, Reliance Industries, Infosys, Tata ...